Abstracts tagged "Arthritis management and infection"

Abstract Number: 2837 • 2017 ACR/ARHP Annual Meeting
Cross-Sectional Analysis of Chikungunya Arthritis Patients 22-Months Post-Infection Demonstrates a Lack of Viral Persistence in Synovial Fluid
Aileen Chang¹, Karen Martins* Contributed equally², Liliana Encinales³, St. Patrick Reid⁴, Marlon Acuña³, Carlos Encinales³, Christian Matranga⁵, Nelly Pacheco³, Carlos Cure³, Bhavarth Shukla⁶, Teofilo Arteta Ruiz³, Richard Amdur⁷, Lisa Cazares⁸, Melissa Gregory⁸, Michael Ward⁸, Alexandra Porras⁹, Alejandro Rico Mendoza⁹, Lian Dong⁸, Tara Kenny⁸, Ernie Brueggemann⁸, Lydia Downey⁸, Priyanka Kamalapathy⁷, Paola Lichtenberger⁶, Orlando Falls³, Gary Simon⁷, Jeffrey Bethony⁷ and Gary S. Firestein¹⁰, ¹Medicine, George Washington University, Washington, DC, ²United States Army Medical Research Institute for Infectious Disease, Frederick, MD, ³Allied Research Society, Baranquilla, Colombia, ⁴University of Nebraska, Omaha, NE, ⁵Broad Institute, Boston, MA, ⁶University of Miami, Miami, FL, ⁷George Washington University, Washington, DC, ⁸United States Army Medical Research Institute of Infectious Disease, Frederick, MD, ⁹Allied Research Society, Bogota, Colombia, ¹⁰Medicine, UCSD, La Jolla, CA
Background/Purpose: Chikungunya virus infection is a mosquito-borne disease that causes chronic joint pain for months to years in approximately one half of infected patients. The…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].